Clinical Pathway in Cardiovascular Disease Management

This chapter review the clinical pathway evolution in cardiovascular disease management and its implementation in Malaysia. We conducted a literature review on the clinical pathway use in cardiovascular disease management. In the nest sections we will give an insight into the situation in Malaysia mainly. In summary, we found that the available evidence on the clinical pathway is scarce and does not help in building strong evidence for evaluating the clinical pathway in Malaysia. The clinical pathway is not a new field in Malaysia. However, interest in reporting the contemporary scientific evidence is scanty. It is necessary to engage the health care researchers on clinical pathway design, implementation and even analysis.